counsels life sciences, food and consumer products companies on a broad range of FDA regulatory, compliance, enforcement and strategic matters. She routinely advises on issues related to product and claims development, and provides guidance that encompasses FDA, FTC, NAD and litigation considerations and risks. Elizabeth also maintains an active pro bono practice. Prior to joining Arnold & Porter, she spent several years as a regulatory counsel in the Office of Regulatory Policy in the FDA's Center for Drug Evaluation and Research. At the FDA, Elizabeth was involved in a wide variety of policy issues involving drug approvals, responded to citizen petitions, developed guidance for industry and counselled on matters relating to Hatch-Waxman marketing exclusivities.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.